Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study
September 2015
in “The Journal of Clinical Endocrinology and Metabolism”
TLDR Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.
In a study of 681 women with polycystic ovary syndrome (PCOS) and 230 referent women, researchers found that androgen levels in women with PCOS decreased with age but remained elevated compared to referent women, even after menopause. The study identified calculated free testosterone (cFT), free androgen index (FAI), and androstenedione (A4) as the best predictive factors for PCOS, with cFT having the highest odds ratio (OR = 7.90) for women under 40 years old. The study concluded that these parameters could be used as diagnostic tools for PCOS across all ages, with cFT being particularly accurate for women under 40 when measured using LC-MS/MS. The study also noted a decrease in oligo-amenorrhea with age in the PCOS group, suggesting more regular menstrual cycles over time. The research was adjusted for BMI differences and highlighted the use of LC-MS for testosterone assay as a strength, but acknowledged its cross-sectional design and the smaller number of referent women as limitations.
View this study on academic.oup.com →
Cited in this study
research Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population
Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.
research Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.
research Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.
research Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.
Related
research Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study
Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.